Low-molecular-weight heparin in addition to low-dose aspirin for preventing preeclampsia and its complications: A systematic review and meta-analysis

Low-molecular-weight heparin in addition to low-dose aspirin for preventing preeclampsia and its complications: A systematic review and meta-analysis

BackgroundIn this systematic review, we aimed to investigate the efficacy and safety of adding low-molecular-weight heparin (LMWH) or unfractionated heparin to low-dose aspirin (LDA) started ≤16 weeks'gestation in the prevention of preeclampsia (PE) in high-risk women.MethodsPubMed, Cochrane Li...

Full description

Bibliographic Details
Main Authors: Li Zheng, Binbin Xia, Yuan Yuan, Yuran Wang, Yan Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
low-dose-aspirin
low-molecular-weight heparin
prevention
preeclampsia
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1073148/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.1073148/full

Similar Items